Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction

Ansar, Saema LU ; Svendgaard, Niels-Aage and Edvinsson, Lars LU (2007) In Journal of Neurosurgery 106(5). p.881-886
Abstract
Object. Cerebral vasospasm following subarachnoid hemorrhage (SAH) leads to reduced cerebral blood flow (CBF) and to cerebral ischemia, in some cases even producing infarction and long-term disability. The goal of the present study was to investigate the hypothesis that inhibition of neurokinin-1 receptors (NK1Rs) by administration of L-822429 blunts the decrease in CBF as well as cerebrovascular receptor upregulation in an animal model of SAH. Methods. Subarachnoid hemorrhage was induced in rats by injection of 250 mu l of blood into the prechiasmatic cistern. The NK1R inhibitor L-822429 was injected intracisternally 30 minutes and 24 hours after the induction of SAH. Two days after SAH induction, the basilar arteries were harvested, and... (More)
Object. Cerebral vasospasm following subarachnoid hemorrhage (SAH) leads to reduced cerebral blood flow (CBF) and to cerebral ischemia, in some cases even producing infarction and long-term disability. The goal of the present study was to investigate the hypothesis that inhibition of neurokinin-1 receptors (NK1Rs) by administration of L-822429 blunts the decrease in CBF as well as cerebrovascular receptor upregulation in an animal model of SAH. Methods. Subarachnoid hemorrhage was induced in rats by injection of 250 mu l of blood into the prechiasmatic cistern. The NK1R inhibitor L-822429 was injected intracisternally 30 minutes and 24 hours after the induction of SAH. Two days after SAH induction, the basilar arteries were harvested, and contractile responses to endothelin-1 (ET-1, an ETA- and ETB-receptor agonist) and 5-carboxamidotryptamine (a 5-hydroxytryptamine-1 [5-HT1]-receptor agonist) were investigated using sensitive myographs. To determine whether NK1R inhibition had an influence on local CBF after post-SAH, a quantitative autoradiographic technique was used. After SAH, the vascular receptor phenotype was changed in cerebral arteries through upregulation of contractile ET, and 5-HT1B receptors, while regional and total CBF were markedly reduced. Treatment with the selective NK1R inhibitor L-822429 prevented both the receptor upregulation and the reduction in regional and global CBF. Conclusions. The data reveal the coregulation of vascular receptor changes and blood flow effects, and also show that interaction with a small-molecule NK1R antagonist is a promising area Of focus for the development of specific treatments for SAH. (Less)
Please use this url to cite or link to this publication:
author
; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Dose-Response Relationship, Animal, Receptors, 5-HT1B: physiology, Muscle, Male, Drug, Injections, Intraventricular, Neurokinin-1: antagonists & inhibitors, Vasospasm, Vasodilator Agents: pharmacology, Up-Regulation: drug effects, Subarachnoid Hemorrhage: physiopathology, Subarachnoid Hemorrhage: drug therapy, Regional Blood Flow: physiology, Regional Blood Flow: drug effects, Intracranial: physiopathology, Intracranial: drug therapy, Neurokinin-1: physiology, Smooth, Vascular: drug effects, Rats, Sprague-Dawley, Receptor, Endothelin B: antagonists & inhibitors, Serotonin, 5-HT1B: antagonists & inhibitors, Animals, Autoradiography, Brain: blood supply, Cerebral Infarction: physiopathology, Cerebral Infarction: prevention & control, Disease Models
in
Journal of Neurosurgery
volume
106
issue
5
pages
881 - 886
publisher
American Association of Neurosurgeons
external identifiers
  • wos:000246047800013
  • scopus:34247862253
ISSN
0022-3085
language
English
LU publication?
yes
id
74abb488-63e4-4ec2-9751-7cb41421709a (old id 663431)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17542534&dopt=Abstract
date added to LUP
2016-04-01 15:22:06
date last changed
2024-01-25 11:43:37
@article{74abb488-63e4-4ec2-9751-7cb41421709a,
  abstract     = {{Object. Cerebral vasospasm following subarachnoid hemorrhage (SAH) leads to reduced cerebral blood flow (CBF) and to cerebral ischemia, in some cases even producing infarction and long-term disability. The goal of the present study was to investigate the hypothesis that inhibition of neurokinin-1 receptors (NK1Rs) by administration of L-822429 blunts the decrease in CBF as well as cerebrovascular receptor upregulation in an animal model of SAH. Methods. Subarachnoid hemorrhage was induced in rats by injection of 250 mu l of blood into the prechiasmatic cistern. The NK1R inhibitor L-822429 was injected intracisternally 30 minutes and 24 hours after the induction of SAH. Two days after SAH induction, the basilar arteries were harvested, and contractile responses to endothelin-1 (ET-1, an ETA- and ETB-receptor agonist) and 5-carboxamidotryptamine (a 5-hydroxytryptamine-1 [5-HT1]-receptor agonist) were investigated using sensitive myographs. To determine whether NK1R inhibition had an influence on local CBF after post-SAH, a quantitative autoradiographic technique was used. After SAH, the vascular receptor phenotype was changed in cerebral arteries through upregulation of contractile ET, and 5-HT1B receptors, while regional and total CBF were markedly reduced. Treatment with the selective NK1R inhibitor L-822429 prevented both the receptor upregulation and the reduction in regional and global CBF. Conclusions. The data reveal the coregulation of vascular receptor changes and blood flow effects, and also show that interaction with a small-molecule NK1R antagonist is a promising area Of focus for the development of specific treatments for SAH.}},
  author       = {{Ansar, Saema and Svendgaard, Niels-Aage and Edvinsson, Lars}},
  issn         = {{0022-3085}},
  keywords     = {{Dose-Response Relationship; Animal; Receptors; 5-HT1B: physiology; Muscle; Male; Drug; Injections; Intraventricular; Neurokinin-1: antagonists & inhibitors; Vasospasm; Vasodilator Agents: pharmacology; Up-Regulation: drug effects; Subarachnoid Hemorrhage: physiopathology; Subarachnoid Hemorrhage: drug therapy; Regional Blood Flow: physiology; Regional Blood Flow: drug effects; Intracranial: physiopathology; Intracranial: drug therapy; Neurokinin-1: physiology; Smooth; Vascular: drug effects; Rats; Sprague-Dawley; Receptor; Endothelin B: antagonists & inhibitors; Serotonin; 5-HT1B: antagonists & inhibitors; Animals; Autoradiography; Brain: blood supply; Cerebral Infarction: physiopathology; Cerebral Infarction: prevention & control; Disease Models}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{881--886}},
  publisher    = {{American Association of Neurosurgeons}},
  series       = {{Journal of Neurosurgery}},
  title        = {{Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction}},
  url          = {{http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17542534&dopt=Abstract}},
  volume       = {{106}},
  year         = {{2007}},
}